CTFA To Seek Clarity On Wrinkle Product Regulatory Status, BSE Rule
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic, Toiletry and Fragrance Association will likely submit a legal memorandum to FDA later this month supporting exclusion of wrinkle removers containing alpha hydroxy and beta hydroxy acids from OTC review, according to President Ed Kavanaugh
You may also be interested in...
CTFA President Kavanaugh To Retire After 31 Years With Trade Group
Cosmetic, Toiletry and Fragrance Association President Ed Kavanaugh will retire in mid-2005, the trade group announced Sept. 24
CTFA President Kavanaugh To Retire After 31 Years With Trade Group
Cosmetic, Toiletry and Fragrance Association President Ed Kavanaugh will retire in mid-2005, the trade group announced Sept. 24
FDA Draws The Line On Wrinkle Reduction Claims In Warning Letter
Wrinkle reduction claims for University Medical Products' Face Lift Collagen 5 products reflect changes to the structure or function of the body, necessitating new drug approval for the products, FDA states in a 1warning letter recently posted to its Web site